Azilasaseong 1mg (Rasagiline Mesylate)

Adult dose

This medicine is administered orally once daily to adults as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy to a dopamine agonist: Administer 1 mg orally once daily. 2) Adjunctive therapy to levodopa: The recommended initial dose for patients taking levodopa is 0.5 mg once daily. If well tolerated but an adequate clinical response is not achieved, the dose may be increased to 1 mg once daily. This medicine may be taken with or without food.

This medication should not be taken by certain patients. Those who are allergic to the active ingredient or other components of this medication should not take it. Additionally, if patients are taking other MAO inhibitors or have stopped using them less than 2 weeks ago, they should not use this medication. Caution is needed when this medication is used with drugs such as petidine, tramadol, and dextromethorphan as it can pose risks. It should not be administered to patients with moderate to severe liver impairment. This medication may cause a variety of side effects. Commonly reported side effects include headache, dizziness, dermatitis, rhinitis, and musculoskeletal pain, and gastrointestinal symptoms such as nausea, vomiting, constipation, and insomnia may occasionally occur. Mentally, symptoms like depression, hallucinations, and confusion may arise, so caution is advised. Additionally, blood pressure may rise or fall suddenly while taking this medication, so it is recommended to periodically check blood pressure status. Due to the risk of interactions with other drugs, it is imperative to consult a physician or pharmacist. Particularly, combining with other MAO inhibitors, antidepressants, sympathomimetics, and certain pain relievers can lead to serious side effects. Using this medication with some cold medications or decongestants is also not recommended. Smokers should be aware that the effectiveness of this medication may be reduced. Pregnant or breastfeeding women should be cautious when using this medication, as it may pass into breast milk and affect breastfeeding. The safety for children and adolescents under 18 has not been confirmed; therefore, it is advisable not to use it in this population. For elderly patients over 65, special dosage adjustments are not necessary, but caution regarding the potential for side effects should be exercised. In case of overdose, serious symptoms such as hypomania, hypertensive crisis, and serotonin syndrome may appear, and immediate medical attention is required. There is no specific antidote for this medication, so symptomatic treatment according to symptoms is necessary. This medication should be stored out of reach of children, and it must be kept in a tightly sealed container to prevent exposure to air and moisture. Ideal storage temperature is in a cool place between 1-25 degrees Celsius.

• Influenza
• skin cancer
• leukopenia
• allergy
• decreased appetite
• depression
• hallucinations
• headache
• cerebrovascular accident
• conjunctivitis

This medication must be stored in a tightly sealed container to prevent air and moisture from entering. A cool storage temperature between 1 and 25 degrees Celsius is suitable.

Appearance

White round tablets

Package unit

Domestic-use - 30 tablets per bottle